Ali Erginay · enciclopedia

Publicaciones › Inteligencia artificial y análisis automático de imágenes

Central retinal thickness following panretinal photocoagulation using a multispot semi‐automated pattern‐scanning laser to treat ischaemic diabetic retinopathy: Treatment in one session compared with four monthly sessions

Espesor retiniano central después de la fotocoagulación panretiniana utilizando un láser de escaneo de patrones semiautomáticos multispot para tratar la retinopatía diabética isquémica: Tratamiento en una sesión en comparación con cuatro sesiones mensuales

Año2018
FuenteActa ophthalmologica
Tipoarticle · Journal Article, Multicenter Study, Randomized Controlled Trial, Equivalence Trial
Autores (11)Pierre-Henry Gabrielle, Pascale Massin, Laurent Kodjikian, Ali Erginay, Charlotte Pallot, Lysiane Jonval, Agnès Soudry, Aude Couturier, Cristina Vardanian-Vartin, Alain M Bron, Catherine Creuzot-Garcher
Posición de Erginay4 de 11
Citas10 (OpenAlex)
EnlacesDOI 10.1111/aos.14002 · PubMed 30561087 · OpenAlex · Texto completo en acceso abierto
LíneasInteligencia artificial y análisis automático de imágenes Edema macular diabético y sus tratamientos Enfermedades vasculares, genéticas e inflamatorias de la retina Retinopatía diabética: clínica, función y progresión Imagen retiniana: OCT, OCT-angiografía y ultra-gran campo

En pocas palabras

Se estudió la efectividad de la fotocoagulación panretiniana en una sesión versus cuatro sesiones para tratar la retinopatía diabética. Los resultados mostraron que no hay diferencia significativa en el espesor retiniano central entre ambos grupos. El estudio sugiere que el tratamiento en una sesión es tan efectivo como el tratamiento en cuatro sesiones para este tipo de retinopatía.

Resumen divulgativo generado automáticamente a partir del resumen original; puede contener imprecisiones.

Resumen original

PURPOSE: To compare central retinal thickness (CRT) after panretinal photocoagulation (PRP) with a multispot semi-automated PAttern-SCAnning Laser (PASCAL) in one session (SS-PRP) versus four monthly sessions (MS-PRP) in diabetic retinopathy. METHODS: Multicentre, prospective, randomized, single-blinded, controlled trial evaluating the noninferiority of SS-PRP versus MS-PRP for CRT measured with macular spectral-domain optical coherence tomography (SD-OCT), with a 9-month follow-up in patients presenting severe nonproliferative diabetic retinopathy (DR) or mild proliferative DR without macular oedema (ME) at baseline. RESULTS: Ninety-seven eyes of 97 participants with a mean age of 57.0 ± 14.2 years were included. The mean change of CRT from baseline to 9 months was not statistically different in SS-PRP or in MS-PRP: +16.9 ± 28.3 μm versus +24.7 ± 31.8 μm, respectively (p = 0.224). The variation in mean best-corrected visual acuity (BCVA) from baseline to 9 months was similar in both groups: -1.1 ± 6.5 letters versus -0.6 ± 6.2 letters (p = 0.684). The number of patients with stabilization of DR was not statistically different between the two groups. No severe complication was recorded in either group. CONCLUSION: This study showed the noninferiority of PRP performed in one session versus four monthly sessions with a PASCAL concerning central retinal thickness for treating mild proliferative or severe nonproliferative DR without ME at baseline.

Términos MeSH

Diabetic Retinopathy Disease Progression Female Fluorescein Angiography Follow-Up Studies Fundus Oculi Humans Laser Coagulation Male Middle Aged Postoperative Period Prospective Studies Retina Single-Blind Method Time Factors Tomography, Optical Coherence Treatment Outcome Visual Acuity